| URL | https://finance.yahoo.com/news/ology-bioservices-i |
| Source | Yahoo Finance |
| Date Published | 03/24/2020 |
| Author Name | PR Newswire |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Ology Bioservices |
| Parent company | Ology Bioservices |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| City reshored to: | Plymouth Meeting |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | DNA medicine |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Lead time/Time to market, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market |